80,000 Shares in Astrana Health, Inc. (NASDAQ:ASTH) Purchased by Rhenman & Partners Asset Management AB

Rhenman & Partners Asset Management AB acquired a new stake in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 80,000 shares of the company's stock, valued at approximately $2,522,000. Rhenman & Partners Asset Management AB owned approximately 0.14% of Astrana Health as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in Astrana Health by 0.4% during the 4th quarter. Vanguard Group Inc. now owns 4,685,959 shares of the company's stock valued at $147,748,000 after acquiring an additional 20,757 shares in the last quarter. State Street Corp purchased a new position in Astrana Health in the third quarter valued at about $91,966,000. Geode Capital Management LLC bought a new position in Astrana Health in the third quarter worth about $58,995,000. FMR LLC purchased a new stake in shares of Astrana Health during the third quarter valued at about $48,413,000. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of Astrana Health by 5.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 471,329 shares of the company's stock valued at $14,861,000 after buying an additional 23,533 shares in the last quarter. 52.77% of the stock is owned by hedge funds and other institutional investors.

Astrana Health Stock Performance

NASDAQ ASTH traded down $0.12 on Thursday, reaching $31.81. 88,131 shares of the company's stock traded hands, compared to its average volume of 269,421. The stock has a 50 day moving average price of $32.55 and a 200-day moving average price of $40.35. The firm has a market cap of $1.59 billion, a price-to-earnings ratio of 24.43, a P/E/G ratio of 1.37 and a beta of 1.04. Astrana Health, Inc. has a fifty-two week low of $23.12 and a fifty-two week high of $63.20. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91.

Astrana Health (NASDAQ:ASTH - Get Free Report) last announced its quarterly earnings results on Thursday, February 27th. The company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of $0.22 by ($0.37). Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The business had revenue of $665.21 million during the quarter, compared to analysts' expectations of $617.24 million. Equities research analysts predict that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

ASTH has been the subject of a number of analyst reports. Bank of America decreased their target price on shares of Astrana Health from $55.00 to $49.00 and set a "buy" rating for the company in a research report on Tuesday, March 4th. Stifel Nicolaus decreased their price objective on Astrana Health from $70.00 to $56.00 and set a "buy" rating for the company in a report on Thursday, February 20th. Truist Financial dropped their target price on Astrana Health from $50.00 to $46.00 and set a "buy" rating on the stock in a research note on Tuesday, March 18th. Macquarie raised Astrana Health to a "hold" rating in a report on Monday, December 16th. Finally, Robert W. Baird cut their price objective on shares of Astrana Health from $86.00 to $50.00 and set an "outperform" rating on the stock in a report on Monday, March 3rd. Three investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $53.29.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.